MyFinsight
Home
Blog
About
Cash and cash
equivalents
$98,490K
(62.70%↑ Y/Y)
Trade and other
receivables, net
$9,326K
(-21.39%↓ Y/Y)
Inventories
$7,366K
(-9.34%↓ Y/Y)
Prepaid expenses and
other current assets
$3,312K
(176.92%↑ Y/Y)
Total current assets
$118,494K
(45.00%↑ Y/Y)
Right-of-use assets, net
$7,949K
(61.86%↑ Y/Y)
Property and equipment,
net
$3,960K
(2.64%↑ Y/Y)
Other non-current
assets
$1,701K
(-46.98%↓ Y/Y)
Total assets
$132,104K
(40.99%↑ Y/Y)
Accumulated deficit
-$477,919K
(-19.57%↓ Y/Y)
Total liabilities and
stockholders deficit
$132,104K
(40.99%↑ Y/Y)
Total stockholders
deficit
-$56,586K
(22.05%↑ Y/Y)
Additional paid-in capital
$421,207K
(28.81%↑ Y/Y)
Common stock, 0.001 par
value. authorized...
$126K
(27.27%↑ Y/Y)
Total liabilities
$188,690K
(13.47%↑ Y/Y)
Liability related to the
sale of future...
$61,168K
(-1.22%↓ Y/Y)
Debt, long-term, net
$50,654K
Royalty obligations,
net
$27,835K
(22.56%↑ Y/Y)
Deferred revenue, net of
current portion
$18,845K
(-5.47%↓ Y/Y)
Total current
liabilities
$16,478K
(-28.84%↓ Y/Y)
Lease liabilities
$7,525K
(61.20%↑ Y/Y)
Other non-current
liabilities
$6,185K
(201.41%↑ Y/Y)
Accounts payable
$8,965K
(-24.99%↓ Y/Y)
Accrued expenses
$4,518K
(-9.66%↓ Y/Y)
Deferred revenue,
current
$1,092K
(0.00%↑ Y/Y)
Liability related to the
sale of future...
$1,000K
(0.00%↑ Y/Y)
Lease liabilities,
current
$820K
(43.86%↑ Y/Y)
Royalty obligations,
current
$51K
(-85.99%↓ Y/Y)
Debt, current
$32K
Back
Back
Balance Sheet
Aquestive Therapeutics, Inc. (AQST)
Aquestive Therapeutics, Inc. (AQST)
source: myfinsight.com